Earlier in October, Pfizer Inc (NYSE ... On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory ... and Abrysvo, made by Pfizer. Earlier this year, the National Advisory Committee on Immunization recommended ...

Novavax is approved for children aged 12 and older. Both Moderna and Pfizer-BioNTech vaccines use messenger RNA (mRNA), which ...

Also Read: DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions In October, the FDA issued the ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...